nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acetylcholinesterase
|
Greenblatt, Harry M. |
|
|
20 |
3 |
p. 369-383 |
artikel |
2 |
Acetylcholinesterase
|
Greenblatt, Harry M. |
|
2003 |
20 |
3 |
p. 369-383 |
artikel |
3 |
Alzheimer neurofibrillary degeneration
|
Iqbal, Khalid |
|
|
20 |
3 |
p. 425-429 |
artikel |
4 |
Alzheimer neurofibrillary degeneration
|
Iqbal, Khalid |
|
2003 |
20 |
3 |
p. 425-429 |
artikel |
5 |
Alzheimer’s therapeutics
|
Massa, Stephen M. |
|
2003 |
20 |
3 |
p. 323-326 |
artikel |
6 |
Alzheimer’s therapeutics
|
Massa, Stephen M. |
|
|
20 |
3 |
p. 323-326 |
artikel |
7 |
Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease
|
Marques, Marcos A. |
|
2003 |
20 |
3 |
p. 327-337 |
artikel |
8 |
A position paper
|
Sparks, D. Larry |
|
|
20 |
3 |
p. 407-410 |
artikel |
9 |
A position paper
|
Sparks, D. Larry |
|
2003 |
20 |
3 |
p. 407-410 |
artikel |
10 |
Calpain inhibitors, a treatment for alzheimer’s disease
|
Battaglia, Fortunato |
|
|
20 |
3 |
p. 357-362 |
artikel |
11 |
Calpain inhibitors, a treatment for alzheimer’s disease
|
Battaglia, Fortunato |
|
2003 |
20 |
3 |
p. 357-362 |
artikel |
12 |
Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol
|
Petanceska, Suzana S. |
|
|
20 |
3 |
p. 395-406 |
artikel |
13 |
Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol
|
Petanceska, Suzana S. |
|
2003 |
20 |
3 |
p. 395-406 |
artikel |
14 |
Characterization of radioiodinated ligand binding to amyloid β plaques
|
Kung, Mei-Ping |
|
|
20 |
3 |
p. 249-253 |
artikel |
15 |
Characterization of radioiodinated ligand binding to amyloid β plaques
|
Kung, Mei-Ping |
|
2003 |
20 |
3 |
p. 249-253 |
artikel |
16 |
Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against β-amyloid induced injury
|
Watterson, D. Martin |
|
|
20 |
3 |
p. 411-423 |
artikel |
17 |
Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against β-amyloid induced injury
|
Watterson, D. Martin |
|
2003 |
20 |
3 |
p. 411-423 |
artikel |
18 |
Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region
|
Payton, Sandra |
|
|
20 |
3 |
p. 267-275 |
artikel |
19 |
Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region
|
Payton, Sandra |
|
2003 |
20 |
3 |
p. 267-275 |
artikel |
20 |
Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives
|
Wang, Yanming |
|
2003 |
20 |
3 |
p. 255-260 |
artikel |
21 |
Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives
|
Wang, Yanming |
|
|
20 |
3 |
p. 255-260 |
artikel |
22 |
Enhancing brain and cognitive function of older adults through fitness training
|
Kramer, Arthur F. |
|
|
20 |
3 |
p. 213-221 |
artikel |
23 |
Enhancing brain and cognitive function of older adults through fitness training
|
Kramer, Arthur F. |
|
2003 |
20 |
3 |
p. 213-221 |
artikel |
24 |
Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer’s disease drug candidate screening
|
Chang, Lei |
|
|
20 |
3 |
p. 305-313 |
artikel |
25 |
Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer’s disease drug candidate screening
|
Chang, Lei |
|
2003 |
20 |
3 |
p. 305-313 |
artikel |
26 |
From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP
|
Gozes, Illana |
|
|
20 |
3 |
p. 315-322 |
artikel |
27 |
From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP
|
Gozes, Illana |
|
2003 |
20 |
3 |
p. 315-322 |
artikel |
28 |
Genetic and environmental epidemiology of Alzheimer’s disease in arabs residing in Israel
|
Farrer, Lindsay A. |
|
|
20 |
3 |
p. 207-212 |
artikel |
29 |
Genetic and environmental epidemiology of Alzheimer’s disease in arabs residing in Israel
|
Farrer, Lindsay A. |
|
2003 |
20 |
3 |
p. 207-212 |
artikel |
30 |
Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment
|
Grundman, Michael |
|
|
20 |
3 |
p. 241-248 |
artikel |
31 |
Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment
|
Grundman, Michael |
|
2003 |
20 |
3 |
p. 241-248 |
artikel |
32 |
Immunological approach for the treatment of Alzheimer’s disease
|
Solomon, Beka |
|
|
20 |
3 |
p. 283-286 |
artikel |
33 |
Immunological approach for the treatment of Alzheimer’s disease
|
Solomon, Beka |
|
2003 |
20 |
3 |
p. 283-286 |
artikel |
34 |
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease
|
Fisher, Abraham |
|
|
20 |
3 |
p. 349-356 |
artikel |
35 |
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease
|
Fisher, Abraham |
|
2003 |
20 |
3 |
p. 349-356 |
artikel |
36 |
Novel glycosaminoglycan precursors as anti-amyloid agents, Part III
|
Kisilevsky, Robert |
|
|
20 |
3 |
p. 291-297 |
artikel |
37 |
Novel glycosaminoglycan precursors as anti-amyloid agents, Part III
|
Kisilevsky, Robert |
|
2003 |
20 |
3 |
p. 291-297 |
artikel |
38 |
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors
|
Rice, Antonie |
|
|
20 |
3 |
p. 339-343 |
artikel |
39 |
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors
|
Rice, Antonie |
|
2003 |
20 |
3 |
p. 339-343 |
artikel |
40 |
Peptide nucleic acids targeted to the amyloid precursor protein
|
McMahon, Beth M. |
|
|
20 |
3 |
p. 261-265 |
artikel |
41 |
Peptide nucleic acids targeted to the amyloid precursor protein
|
McMahon, Beth M. |
|
2003 |
20 |
3 |
p. 261-265 |
artikel |
42 |
Potential use of estrogen-like drugs for the prevention of Alzheimer’s disease
|
Smith, Jonathan D. |
|
|
20 |
3 |
p. 277-281 |
artikel |
43 |
Potential use of estrogen-like drugs for the prevention of Alzheimer’s disease
|
Smith, Jonathan D. |
|
2003 |
20 |
3 |
p. 277-281 |
artikel |
44 |
Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors
|
Lazareno, Sebastian |
|
|
20 |
3 |
p. 363-367 |
artikel |
45 |
Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors
|
Lazareno, Sebastian |
|
2003 |
20 |
3 |
p. 363-367 |
artikel |
46 |
Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites
|
Mruthinti, Shyamala |
|
|
20 |
3 |
p. 223-232 |
artikel |
47 |
Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites
|
Mruthinti, Shyamala |
|
2003 |
20 |
3 |
p. 223-232 |
artikel |
48 |
β-secretase processing of the Alzheimer’s amyloid protein precursor (APP)
|
Marlow, Laura |
|
|
20 |
3 |
p. 233-239 |
artikel |
49 |
β-secretase processing of the Alzheimer’s amyloid protein precursor (APP)
|
Marlow, Laura |
|
2003 |
20 |
3 |
p. 233-239 |
artikel |
50 |
Steroid hormones and cognitive functioning in aging men
|
Sherwin, Barbara B. |
|
|
20 |
3 |
p. 385-393 |
artikel |
51 |
Steroid hormones and cognitive functioning in aging men
|
Sherwin, Barbara B. |
|
2003 |
20 |
3 |
p. 385-393 |
artikel |
52 |
Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors
|
Zeng, Lei |
|
2003 |
20 |
3 |
p. 345-348 |
artikel |
53 |
Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors
|
Zeng, Lei |
|
|
20 |
3 |
p. 345-348 |
artikel |
54 |
Study of memapsin 2 (β-secretase) and strategy of inhibitor design
|
Tang, Jordan |
|
|
20 |
3 |
p. 299-304 |
artikel |
55 |
Study of memapsin 2 (β-secretase) and strategy of inhibitor design
|
Tang, Jordan |
|
2003 |
20 |
3 |
p. 299-304 |
artikel |
56 |
The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer’s disease
|
Melchor, Jerry P. |
|
|
20 |
3 |
p. 287-289 |
artikel |
57 |
The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer’s disease
|
Melchor, Jerry P. |
|
2003 |
20 |
3 |
p. 287-289 |
artikel |